Name | N,N',N'',N''',N'''',N'''''-Hexaacetyl chitohexaose |
Synonyms | Brn 0001006 N-acetylated chitohexaose HEXA-(N-ACETYL) CHITOHEXAOSE Chitohexaose, hexa-N-acetyl (6ci) N,N',N'',N''',N'''',N'''''-Hexaacetylchitohexaose N,N',N'',N''',N'''',N'''''-Hexaacetyl chitohexaose N,N',N'',N''',N'''',N'''''-Hexa-O-acetylchitohexaose GLCNAC1-B-4-GLCNAC1-B-4-GLCNAC1-B-4GLCNAC1-B-4GLCNAC1-B-4GLCNAC GLCNAC-BETA1-4GLCNAC-BETA1-4GLCNAC-BETA1-4GLCNAC-BETA1-4GLCNAC-BETA1-4GLCNAC D-Glucose, o-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1-4)-o-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1-4)-o-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1-4)-o-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1-4)-o-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1-4)-2-(acetylamino)-2-deoxy- |
CAS | 38854-46-5 |
Molecular Formula | C48H80N6O31 |
Molar Mass | 1237.17 |
Density | 1.60±0.1 g/cm3(Predicted) |
Melting Point | >250°C (dec.) |
Boling Point | 1652.6±65.0 °C(Predicted) |
Specific Rotation(α) | -11.4 º (in H2O) |
Solubility | Soluble in Water |
Appearance | Solid |
Color | White to Off-White |
pKa | 12.72±0.70(Predicted) |
Storage Condition | −20°C |
Stability | Hygroscopic |
MDL | MFCD00210241 |
In vivo study | On sarcoma 180 solid tumor in ddY mice using lentinan, an antitumorβ-D-glucan, as the positive control. Hexa-N-acetylchitohexaose (100 mg/kg/day; 3 times; intravenous ) significantly inhibits the growth of this allogenic solid tumor, affording a high tumor growth-inhibition ratio (85%) at 7 days after tumor implantation. |
Safety Description | 24/25 - Avoid contact with skin and eyes. |
WGK Germany | 3 |
RTECS | LZ6653000 |
HS Code | 29400090 |
biological activity | Hexa-N-acetylchitohexaose is an inducer of crop disease resistance and can induce the increase of soybean lignification-related enzymes and antioxidant enzyme activities. Hexa-N-acetylchitohexaose is the substrate of lysozyme. Hexa-N-acetylchitohexaose has anti-tumor effect. |
in vivo study | on sarcoma 180 solid tumor in ddY mice using lentinan, an antitumorβ-D-glucan, as the positive control. Hexa-N-acetylchitohexaose (100 mg/kg/day; 3 times; intravenous ) significantly inhibits the growth of this allogenic solid tumor, affording a high tumor growth-inhibition ratio (85%) at 7 days after tumor implantation. |